Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations

Front Neurol. 2023 Feb 1:14:1143410. doi: 10.3389/fneur.2023.1143410. eCollection 2023.

Alberto Vogrig^{1

2}, Cristina Valencia-Sanchez³, Jérôme Honnorat^{4

5}, Sergio Muñiz-Castrillo⁶

¹ Clinical Neurology, Udine University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy.
² Department of Medical Area (DAME), University of Udine, Udine, Italy.
³ Department of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
⁴ French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hôpital Neurologique, Hospices Civils de Lyon, Bron, France.
⁵ Team SynatAc, MeLiS Institute-UCBL-CNRS UMR 5284-INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France.
⁶ Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, United States.

No abstract available

Keywords: MOGAD; NMOSD; autoimmune encephalitis; autoimmune epilepsy; paraneoplastic neurological syndromes.

Publication types